journal article·2024-05-04Open access

Molecular Simulations of Unexplored Philippine Plant Constituents on the Inhibition of the Proinflammatory Marker NF-κB p50 Subunit

Jasmine U. Ting, Maria Carmen S. Tan, Vincent Antonio S. Ng, Stephani Joy Y. Macalino, Virgilio C. Linis, Glenn G. Oyong

Crystals· Volume 14· Issue 5

Abstract

Inflammation serves as a pivotal defense mechanism orchestrated by the innate immune system to safeguard cellular health against adversities. Nonetheless, dysregulated inflammatory responses can precipitate chronic inflammatory ailments, notably autoimmune disorders. Central to this process are various pathways, with studies highlighting the pivotal role of transcription factors within the nuclear factor-kappa B (NF-κB) signaling pathway in disease onset and progression. This study concentrates on the p50 homodimer protein, a key transcription factor pivotal for the expression of proinflammatory cytokine genes. To explore potential inhibitors of p50, we conducted in silico procedures to investigate fifty-eight unexplored compounds, derived from plants indigenous to the Philippines. Initial screenings for compound feasibility, through drug-likeness analyses, yielded positive outcomes for 34 compounds. Subsequent docking analyses revealed six compounds exhibiting binding energies (ranging from −3.7 to −4.2 kcal/mol) akin to or lower than the positive control, dexamethasone (−3.7 kcal/mol). These compounds include eudesm-11-en-4α-O-β-D-3-tigoyloxy-6-deoxy-glucopyranoside, wadeiol, grandiflorolide, eudesm-11-en-4α-O-β-D-3-senecioyloxy-6-deoxyglucopyranoside, α-pinene-7β-O-β-D-2- acetylglucopyranoside, and (2aβ,3α,5aβ,6β,7α,8aα)-6-[2-(3-furanyl)ethyl]-2a,3,4,5,5a,6,7,8,8a,8b- decahydro-2a,3-dihydroxy-6,7,8b-trimethyl-2H-naphtho[1-8-bc]furan-2-one. Interaction analyses revealed a common engagement of amino acid residues within the p50 DNA binding pocket, notably Arg57, Tyr60, Glu63, Lys244, Ala245, Pro246, Lys275, Arg308, Gln309, and Phe310, through hydrogen bonding, van der Waals forces, alkyl, and pi–alkyl interactions. Pharmacophore analysis underscored aromatic rings, hydroxyl, methyl, and methylene groups as pivotal for non-covalent interactions with p50. Additionally, root mean square fluctuation (RMSF) analysis demonstrated minimal residue fluctuations in p50 upon ligand binding compared to the ligand-free protein structure. In conclusion, the six shortlisted compounds exhibiting comparable binding affinities with dexamethasone hold promise as potential anti-inflammatory agents targeting the NF-κB p50 homodimer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Natural product bioactivities and synthesis · NF-κB Signaling Pathways · Bioactive Compounds and Antitumor Agents

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, De La Salle University, 2401 Taft Avenue, Malate, Manila 0922, Philippines

School of Multidisciplinary Studies, De La Salle-College of Saint Benilde, 2544 Taft Avenue, Malate, Manila 0922, Philippines

Department of Physics, De La Salle University, 2401 Taft Avenue, Malate, Manila 0922, Philippines

References (78)

Show source-provided references
1. The Evolution of Plant Secretory Structures and Emergence of Terpenoid Chemical Diversity10.1146/annurev-arplant-043014-114639 ↗
2. Phytochemicals: Nutraceuticals and human health10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W ↗
3. The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4/NF-κB-mediated inflammation10.3389/fimmu.2021.606069 ↗
4. Terpenoids: Natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential10.1007/s00018-008-8103-5 ↗
5. Shin, S.A., Joo, B.J., Lee, J.S., Ryu, G., Han, M., Kim, W.Y., Park, H.H., Lee, J.H., and Lee, C.S. (2020). Phytochemicals as anti-inflammatory agents in animal models of prevalent inflammatory diseases. Molecules, 25.10.3390/molecules25245932 ↗
6. Anti-inflammatory effects of a novel peptide designed to bind with NF-κB p50 subunit10.1111/j.1745-7254.2006.00442.x ↗
7. The Biological Functions of NF-κB1 and its potential as anti-cancer target10.2174/156800909788486759 ↗
8. Innate Immune Cells in Inflammation and Cancer10.1158/2326-6066.CIR-13-0081 ↗
9. Regulation of inflammation by short chain fatty acids10.3390/nu3100858 ↗
10. Role of NF-κB activation in intestinal immune homeostasis10.1016/j.ijmm.2009.08.007 ↗
11. NFκB1: A Suppressor of Inflammation, Ageing and Cancer10.1111/febs.13627 ↗
12. NF-κB Signaling in Inflammation10.1038/sigtrans.2017.23 ↗
13. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging10.1016/j.arr.2007.09.002 ↗
14. Inhibition of Nuclear Factor-ΚB DNA Binding by Organoselenocyanates through Covalent Modification of the P50 Subunit10.1158/0008-5472.CAN-07-2510 ↗
15. New eudesmanolide sesquiterpenes from a Philippines collection of Wedelia prostata10.1021/np50093a011 ↗
16. Germacranolides from Pseudoelephantopus spicatus10.1016/0031-9422(93)85461-Y ↗
17. Tetranortriterpenoids from Azadirachta indica10.1016/S0031-9422(97)87092-6 ↗
18. Sesquiterpene glycosides from Pittosporum pentandrum10.1016/S0031-9422(96)00852-7 ↗
19. Bioactive monoterpene glycosides from Erigeron linifolius10.1016/S0031-9422(97)00223-9 ↗
20. A Triterpene from Ficus pumila10.1080/10286029908039875 ↗
21. Clerodane Diterpenes from Tinospora rumphii10.1021/np9902946 ↗
22. Diastereomeric diterpenes from Coleus blumei10.1248/cpb.49.927 ↗
23. An antifungal cadinanolide from Pseudoelephantopus spicatus10.1248/cpb.49.1359 ↗
24. Ionone derivatives from Alternanthera sessilis10.1080/10286020290027380 ↗
25. New Furanoid Diterpenes from Caesalpinia pulcherrima10.1021/np0201523 ↗
26. A New Furanoid Diterpene from Caesalpinia pulcherrima10.1248/cpb.51.1208 ↗
27. A New cycloartenol esters from Ixora coccinea10.1080/14786410310001630519 ↗
28. Terpenoids and Sterols from Lagerstroemia speciosa10.1080/10286020310001596024 ↗
29. Monoterpene Lactones from the Seeds of Nephelium appaceum10.1021/np0580053 ↗
30. Iridoids from Gardenia jasminoides10.1080/14786410701589998 ↗
31. A Chromomoric acid derivatives from Tectona philippinensis10.1021/np0704304 ↗
32. A New Sesquiterpene from Artemisia vulgaris10.1007/s11418-008-0253-0 ↗
33. New carvotanacetone derivatives from Sphaeranthus africanus10.1055/s-0029-1186031 ↗
34. New Triterpenes from Barringtonia asiatica10.1248/cpb.59.778 ↗
35. A New Triterpene from Atalantia retusa Merr10.5560/znb.2012-0026 ↗
36. Cytotoxic Triterpene from Barringtonia asiatica10.1007/s11094-014-1144-1 ↗
37. Chemical Constituents of Cinnamomum cebuense
38. Glabretal-type triterpenoids from Dysoxylum mollissimum10.1016/j.phytol.2013.06.010 ↗
39. New triterpenes from the bark of Canarium asperum
40. A New Triterpene from Glinus oppositifolius10.3724/SP.J.1009.2012.00284 ↗
41. An isopimarane diterpene from Cycas sancti-lasallei
42. An isoflavonoid phtoalexin and a sesquiterpene from Cycas wadei
43. A new sesquiterpene from Dendranthema grandiflora flowers10.1007/s10600-020-03057-4 ↗
44. A Bioactive Triterpene from Lantana camara10.1016/S0031-9422(96)00805-9 ↗
45. A diterpene from Bidens pilosa10.1016/0031-9422(94)00793-S ↗
46. (ACD/ChemSketch, 2020). ACD/ChemSketch, version 2020.2.26.
47. Open Babel: An Open Chemical Toolbox10.1186/1758-2946-3-33 ↗
48. ADMETlab 2.0: An Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties10.1093/nar/gkab255 ↗
49. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading10.1002/jcc.21334 ↗
50. GROMACS: A message-passing parallel molecular dynamics implementation10.1016/0010-4655(95)00042-E ↗
51. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes
52. VMD—Visual Molecular Dynamics10.1016/0263-7855(96)00018-5 ↗
53. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers10.1016/j.softx.2015.06.001 ↗
54. PharmaGist: A webserver for ligand-based pharmacophore detection10.1093/nar/gkn187 ↗
55. (Discovery Studio Visualizer, 2020). Discovery Studio Visualizer, version 21.1.0.20298.
56. Assessment of Protein Models with Three-Dimensional Profiles10.1038/356083a0 ↗
57. Arnold, E., Himmel, D.M., and Rossmann, M.G. (2011). International Tables for Crystallography: Crystallography of Biological Macromolecules, John Wiley and Sons. [2nd ed.].10.1107/97809553602060000111 ↗
58. BDDCS, the Rule of 5 and Drugability10.1016/j.addr.2016.05.007 ↗
59. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic10.1016/j.ejphar.2021.173854 ↗
60. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cells10.1016/j.cbi.2005.10.105 ↗
61. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study10.1038/s41392-020-00312-6 ↗
62. Chlorogenic acid induces apoptosis to inhibit inflammatory proliferation of IL-6-induced fibroblast-like synoviocytes through modulating the activation of JAK/STAT and NF-κB signaling pathways10.3892/etm.2016.3136 ↗
63. Anti-inflammatory effects of compounds alpha-humulene and (−)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea10.1016/j.ejphar.2007.04.059 ↗
64. Structure of the NF-kB p50 Homodimer Bound to DNA10.1038/373311a0 ↗
65. PBD Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease10.1080/07391102.2020.1815584 ↗
66. Implications of protein flexibility for drug discovery10.1038/nrd1129 ↗
67. Flexibility and Conformational Entropy in Protein-Protein Binding10.1016/j.str.2006.06.003 ↗
68. In silico drug repurposing for coronavirus (COVID-19): Screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensins-converting enzyme 2(ACE-2) (6M0J)
69. Regulation of protein-ligand binding affinity by hydrogen bond pairing10.1126/sciadv.1501240 ↗
70. ADMET-score—A comprehensive scoring function for evaluation of chemical drug-likeness10.1039/C8MD00472B ↗
71. P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement10.1016/S1043-6618(03)00158-0 ↗
72. Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development10.2133/dmpk.DMPK-10-RV-062 ↗
73. Improvement in solubility of poor water-soluble drugs by solid dispersion10.4103/2230-973X.96921 ↗
74. Kumar, A., and Jernigan, R.L. (2021). Ligand Binding Introduces Significant Allosteric Shifts in the Locations of Protein Fluctuations. Front. Mol. Biosci., 8.10.3389/fmolb.2021.733148 ↗
75. The Structural Basis of Allosteric Regulation in Proteins10.1016/j.febslet.2009.03.019 ↗
76. QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery10.3389/fphar.2018.01275 ↗
77. Drug delivery systems: An updated review10.4103/2230-973X.96920 ↗
78. Improvement in Aqueous Solubility of Achiral Symmetric Cyclofenil by Modification to a Chiral Asymmetric Analog10.1038/s41598-021-92028-y ↗